Climb Bio, Inc.
USD12.70
+0.12 (+0.95%)
CEO
Aoife Brennan BCh MMSc
IPO Date
2021-08-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.30
Prev. Close
$12.58
Day Low
$12.14
Day High
$13.53
52W Low
$1.36
52W High
$14.41
Market Cap
$0.87B
Volume
1.36M
| 70,284 |
| $13.36 |
| 1 Jul 2026 | Celebi Breanna Maurine | director | A-Award | Acquired | 70,284 | $13.36 |
| 30 Jun 2026 | Brennan Aoife | director, officer: President and CEO | M-Exempt | Acquired | 68,750 | $0.00 |
| 30 Jun 2026 | Brennan Aoife | director, officer: President and CEO | S-Sale | Disposed | 30,902 | $13.17 |
| 30 Jun 2026 | Brennan Aoife | director, officer: President and CEO | M-Exempt | Disposed | 68,750 | $0.00 |
| 8 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | Levin Andrew David | director | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | Drapkin Kimberlee C | director | A-Award | Acquired | 40,000 | $10.55 |
| 8 Jun 2026 | WILLIAMS DOUGLAS E | director | A-Award | Acquired | 40,000 | $10.55 |